Ahn-Gook Pharmaceutical Co. Ltd Capital Reinvestment Ratio
Ahn-Gook Pharmaceutical Co. Ltd capital reinvestment ratio. Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩14.44 Billion) in capital expenditures (₩2.76 Billion). Check how aggressively does Ahn-Gook Pharmaceutical Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Capital reinvestment ratio of Ahn-Gook Pharmaceutical Co. Ltd from 2012 to 2024. This chart tracks Ahn-Gook Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Also explore net asset growth rate of Ahn-Gook Pharmaceutical Co. Ltd to track the company's year-over-year net asset growth rate.
Ahn-Gook Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2012–2024)
Ahn-Gook Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2012 to 2024. For the full cash flow conversion analysis, see Ahn-Gook Pharmaceutical Co. Ltd (001540) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 15.44x | ₩4.91 Billion | ₩75.89 Billion | ▲ +842.3% |
| 2022 | 1.64x | ₩1.79 Billion | ₩2.93 Billion | ▼ -40.2% |
| 2021 | 2.74x | ₩1.47 Billion | ₩4.04 Billion | ▲ +27.2% |
| 2020 | 2.16x | ₩11.19 Billion | ₩24.12 Billion | ▲ +1173.0% |
| 2019 | 0.17x | ₩22.08 Billion | ₩3.74 Billion | ▼ -38.3% |
| 2017 | 0.27x | ₩17.46 Billion | ₩4.79 Billion | ▼ -20.9% |
| 2016 | 0.35x | ₩12.62 Billion | ₩4.38 Billion | ▲ +184.5% |
| 2015 | 0.12x | ₩19.11 Billion | ₩2.33 Billion | ▼ -97.8% |
| 2014 | 5.56x | ₩1.29 Billion | ₩7.16 Billion | ▲ +207.2% |
| 2013 | 1.81x | ₩3.64 Billion | ₩6.60 Billion | ▲ +708.3% |
| 2012 | 0.22x | ₩11.51 Billion | ₩2.58 Billion | — |